SCHEMBL14882575

SCHEMBL14882575

CC(C)c1cccc(C(C)C)c1-c1cc2sc3cc(-c4cc5sc6cc(-c7c(C(C)C)cccc7C(C)C)sc6c5s4)sc3c2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 3/20 0.36
▸ GABRG2 P18507 2/20 0.36
▸ GABRB3 P28472 2/20 0.36
▸ GABRB2 P47870 2/20 0.36
▸ FAAH O00519 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ GABRA2 P47869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14225396 0.98 GABRA1 (0.38) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL10053978 0.78 LIMK1 (0.36) GABRA1GABRB2CA1CA2
SCHEMBL10053976 0.76 LIMK1 (0.37) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL15090324 0.74 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL19521963 0.73 ALDH1A1 (0.36) CA1CA2LMNACYP1A2TSHR
SCHEMBL14225408 0.72 CA1 (0.39) CA1CA2HTR2CHTR2B
SCHEMBL14882391 0.71 CA2 (0.36) GABRA1GABRB2CA2TSHR
SCHEMBL14225403 0.69 CA2 (0.38) GABRA1GABRB2CA2TSHR
SCHEMBL14225406 0.69 APP (0.40) CA1CA2LMNACYP3A4HPGD
SCHEMBL10054567 0.69 SLC9A1 (0.35) LMNAHPGDTSHRHIF1ASLC9A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588484-B1 ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME CANON KK (JP) 2015-11-04 — — EP disclosed
US-8982443-B2 Organic compound and electrochromic device including the same CANON KABUSHIKI KAISHA (JP) 2015-03-17 — — US disclosed
US-8982443-B2 Organic compound and electrochromic device including the same CANON KABUSHIKI KAISHA (JP) 2015-03-17 — — US disclosed
US-20130100517-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-04-25 — — US disclosed
US-20130100517-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-04-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130100517-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME CCNL2, DNMT3L, ARL1 GABRA1 3772/4885GABRG2 4394/4885GABRB3 3870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback